Ionis Pharmaceuticals/ US4622221004 /

9/29/2023 7:35:58 PM	Chg. -0.75	Volume	Bid7:36:22 PM	Ask7:36:22 PM	High	Low
45.53USD	-1.62%	21,755 Turnover: 999,025.79	45.40Bid Size: 200	49.42Ask Size: 100	46.77	45.42

GlobeNewswire 3/28/2022 Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotroph...

GlobeNewswire 3/17/2022 Ring Therapeutics Announces the Appointment of Industry Leaders to its Board of Directors

GlobeNewswire 3/14/2022 Biogen Announces New Updates Across its SMA Research Program at 2022 MDA Conference

GlobeNewswire 3/9/2022 Antisense Therapeutics to present poster at world’s largest NMD conference

GlobeNewswire 2/24/2022 ProQR Announces Fourth Quarter and Full Year 2021 Operating and Financial Results

GlobeNewswire 2/2/2022 n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines for Patients with Nano-rare D...

GlobeNewswire 1/4/2022 Biogen Exercises Option with Ionis to Develop and Commercialize Investigational ASO for SMA

GlobeNewswire 1/3/2022 Indaptus Therapeutics Announces Appointment of Boyan Litchev, M.D. as Chief Medical Officer

GlobeNewswire 12/10/2021 Cytokinetics Announces Data From Its ALS Program Presented at the 32nd International Symposium on AL...

GlobeNewswire 11/18/2021 ProQR Announces Highlights from Analyst Event

GlobeNewswire 11/15/2021 CoImmune, Inc. Appoints Ed Baracchini, PhD, Chairman of the Board of Directors

GlobeNewswire 11/4/2021 ProQR Announces Third Quarter 2021 Operating and Financial Results

GlobeNewswire 10/17/2021 Biogen Announces Topline Results from the Tofersen Phase 3 Study and its Open-Label Extension in SOD...

GlobeNewswire 10/14/2021 Topline Results from Tofersen Phase 3 Study and its Open Label Extension in SOD1-ALS to be Presented...

GlobeNewswire 10/13/2021 Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Prope...

GlobeNewswire 9/21/2021 Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multi...

GlobeNewswire 9/21/2021 Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference

GlobeNewswire 9/15/2021 Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen ...

GlobeNewswire 9/8/2021 Eloxx Pharmaceuticals Appoints Chief Medical Officer

GlobeNewswire 8/5/2021 ProQR Announces Second Quarter 2021 Operating and Financial Results

GlobeNewswire 7/15/2021 Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director

GlobeNewswire 6/10/2021 New Data at Cure SMA 2021 Highlight the Long-Term Efficacy of SPINRAZA® (nusinersen) and Biogen’s Co...

GlobeNewswire 6/9/2021 Flexion Therapeutics Announces Appointment of William T. Andrews, M.D., F.A.C.P., as Chief Medical O...

GlobeNewswire 5/24/2021 Dr. Lisa Johnson-Pratt Joins Assembly Biosciences Board of Directors

GlobeNewswire 5/18/2021 Alex Howarth Joins Madrigal Pharmaceuticals as Chief Financial Officer